US Dollar vs Yen

登録してリアルタイムのアラート、カスタムポートフォリオ、市場の動きを入手してください。

登録

ホーム
投資
株式
アメリカ
NASDAQ
Anixa Biosciences Inc (ANIX)
Anixa Biosciences Inc (ANIX) ニュース

ANIX

Anixa Biosciences (ANIX)

Anixa Biosciences Inc

から:

Regulatory News

Text Search:

次の項目別のソート:

Non-Regulatory News

Showing the most relevant articles for your search:NASDAQ:ANIX

1 2 3 4 5 6 7 8 9 10 次へ >>

日付	受信時刻	ニュースソース	見出し	コード	企業名
2024/05/08	21 : 35	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:ANIX	Anixa Biosciences Inc
2024/05/08	21 : 25	PR Newswire (US)	Anixa Biosciences Expands Partnership with Cleveland Clinic to Develop Additional Cancer Vaccines	NASDAQ:ANIX	Anixa Biosciences Inc
2024/05/06	21 : 05	PR Newswire (US)	Anixa Biosciences CEO Featured on "Target: Cancer Podcast" by Oncologist Dr. Sanjay Juneja	NASDAQ:ANIX	Anixa Biosciences Inc
2024/04/30	20 : 45	PR Newswire (US)	Anixa Biosciences to Participate in the Sidoti Micro-Cap Virtual Conference on May 8 & 9, 2024	NASDAQ:ANIX	Anixa Biosciences Inc
2024/04/18	21 : 20	PR Newswire (US)	Anixa Biosciences Welcomes Celebrity Oncologist Dr. Sanjay Juneja to its Cancer Business Advisory Board	NASDAQ:ANIX	Anixa Biosciences Inc
2024/03/14	21 : 45	PR Newswire (US)	Anixa Biosciences 2024 Annual Meeting of Stockholders to Include Investor Presentation Open to All Interested Parties	NASDAQ:ANIX	Anixa Biosciences Inc
2024/03/11	21 : 00	PR Newswire (US)	Anixa Biosciences Announces Presentation at 24th Annual World Vaccine Congress	NASDAQ:ANIX	Anixa Biosciences Inc
2024/02/12	21 : 30	PR Newswire (US)	Anixa Biosciences Initiates Dosing in Second Cohort of Ovarian Cancer CAR-T Clinical Trial	NASDAQ:ANIX	Anixa Biosciences Inc
2024/02/09	06 : 15	Edgar (US Regulatory)	Form DEF 14A - Other definitive proxy statements	NASDAQ:ANIX	Anixa Biosciences Inc
2024/01/29	22 : 50	PR Newswire (US)	Anixa Biosciences Announces Participation in 2024 NeauxCancer Oncology Conference	NASDAQ:ANIX	Anixa Biosciences Inc
2024/01/23	21 : 55	PR Newswire (US)	Anixa Biosciences Announces Japanese Patent on Ovarian Cancer Vaccine Technology	NASDAQ:ANIX	Anixa Biosciences Inc
2024/01/17	09 : 08	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:ANIX	Anixa Biosciences Inc
2024/01/17	09 : 07	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:ANIX	Anixa Biosciences Inc
2024/01/17	09 : 07	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:ANIX	Anixa Biosciences Inc
2024/01/17	09 : 05	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:ANIX	Anixa Biosciences Inc
2024/01/17	09 : 05	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:ANIX	Anixa Biosciences Inc
2024/01/17	07 : 29	Edgar (US Regulatory)	Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]	NASDAQ:ANIX	Anixa Biosciences Inc
2024/01/17	06 : 43	Edgar (US Regulatory)	Form S-8 - Securities to be offered to employees in employee benefit plans	NASDAQ:ANIX	Anixa Biosciences Inc
2024/01/17	06 : 30	Edgar (US Regulatory)	Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]	NASDAQ:ANIX	Anixa Biosciences Inc
2024/01/10	23 : 00	PR Newswire (US)	Anixa Biosciences to Present at Sidoti Micro-Cap Virtual Conference on January 17, 2024	NASDAQ:ANIX	Anixa Biosciences Inc
2023/12/14	21 : 15	PR Newswire (US)	Anixa Biosciences to Present at Biotech Showcase 2024	NASDAQ:ANIX	Anixa Biosciences Inc
2023/12/07	20 : 01	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:ANIX	Anixa Biosciences Inc
2023/12/07	08 : 00	PR Newswire (US)	Anixa Biosciences and Cleveland Clinic Present Positive New Data from Phase 1 Study of Breast Cancer Vaccine	NASDAQ:ANIX	Anixa Biosciences Inc
2023/12/07	06 : 05	PR Newswire (US)	Anixa Biosciences to Host Conference Call This Evening to Discuss Positive New Data from Ongoing Phase 1 Study of Breast Cancer Vaccine	NASDAQ:ANIX	Anixa Biosciences Inc
2023/11/27	22 : 30	PR Newswire (US)	Anixa Biosciences Announces European Patent on Ovarian Cancer Vaccine Technology	NASDAQ:ANIX	Anixa Biosciences Inc
2023/11/02	23 : 58	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:ANIX	Anixa Biosciences Inc
2023/10/31	21 : 30	PR Newswire (US)	Anixa Biosciences to Present at the Ovarian Cancer Research Alliance (OCRA) Ovarian Cancer National Conference	NASDAQ:ANIX	Anixa Biosciences Inc
2023/10/23	21 : 30	PR Newswire (US)	Anixa Biosciences Appoints Accomplished Medical Oncologist and Biotechnology Executive, Dr. Mark A. Goldberg, to Cancer Business Advisory Board	NASDAQ:ANIX	Anixa Biosciences Inc
2023/10/13	21 : 30	PR Newswire (US)	Anixa Biosciences Completes Treatment of First Patient Cohort in Ovarian Cancer CAR-T Clinical Trial	NASDAQ:ANIX	Anixa Biosciences Inc
2023/10/11	23 : 35	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:ANIX	Anixa Biosciences Inc

Showing the most relevant articles for your search:NASDAQ:ANIX

1 2 3 4 5 6 7 8 9 10 次へ >>

Akbank 5.000% S

ICTS International NV (QB)

Kermode Resources (PK)

Desjardins RI USA Multif...

Dividend 15 Split Corp II

Delivery Technology Solu... (CE)

Delayed Upgrade Clock

顧客サポート: +44 (0) 203 8794 460 | support@advfn.com

ADVFNのサービスをご利用いただくには、利用規約